List of insiders holdings for WINDTREE THERAPEUTICS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Lee's Pharmaceutical Holdings Ltd 10% Owner | 2019-12-10 19:54:04 | 0 15,278,414 | 15,278,414 | Form 4 |
| 2 | Center Laboratories Inc. 10% Owner | 2022-01-10 17:03:57 | 1,239,088 5,095,014 | 6,334,102 | Form 4 |
| 3 | Bioengine Capital Inc. 10% Owner | 2022-01-10 17:03:07 | 3,855,926 0 | 3,855,926 | Form 4 |
| 4 | CAPETOLA ROBERT J Former President/CEO | 2010-02-09 17:15:50 | 418,479 17,938 | 436,417 | Form 5 |
| 5 | SCHABER CHRISTOPHER Exec. VP & COO | 2006-01-05 16:43:24 | 287,771 0 | 287,771 | Form 4 |
| 6 | ESTEVE ANTONIO PHD Director | 2012-06-12 16:23:10 | 60,341 213,438 | 273,779 | Form 4 |
| 7 | COOPER JOHN G President & CEO | 2015-07-24 16:36:50 | 105,980 47,511 | 153,491 | Form 4 |
| 8 | Magee Michael L VP, Quality Operations | 2015-03-31 16:33:53 | 100,000 31,388 | 131,388 | Form 4 |
| 9 | Cole Kathy Senior VP, Human Resources | 2015-03-31 16:30:47 | 86,667 39,419 | 126,086 | Form 4 |
| 10 | NIVEN RALPH SVP-Preclinical Dev-Former | 2005-06-03 11:59:15 | 103,265 0 | 103,265 | Form 4 |
| 11 | Hamill John P. SVP & CFO | 2022-07-26 16:38:04 | 72,800 0 | 72,800 | Form 4 |
| 12 | Clayton Russell Senior VP, R&D | 2014-03-10 16:43:16 | 53,466 18,854 | 72,320 | Form 4 |
| 13 | LINK MAX Director | 2012-06-12 16:24:49 | 71,121 0 | 71,121 | Form 4 |
| 14 | Osterman Mark G SVP, Sales and Marketing | 2006-01-05 16:31:50 | 57,074 0 | 57,074 | Form 4 |
| 15 | Miller Thomas F SVP, Chief Operating Officer | 2015-02-17 17:07:08 | 15,460 39,540 | 55,000 | Form 5 |
| 16 | Amick W Thomas Chief Executive Officer | 2013-02-13 16:52:21 | 29,333 15,957 | 45,290 | Form 5 |
| 17 | Hoy Thomas VP, Manufacturing Ops. | 2015-02-17 16:57:42 | 6,667 36,212 | 42,879 | Form 5 |
| 18 | Curtis Eric SVP & COO | 2023-08-25 18:00:05 | 37,920 0 | 37,920 | Form 4 |
| 19 | ZODDA DENI M PHD Sr VP, Business Development | 2006-01-05 17:03:46 | 36,949 0 | 36,949 | Form 4 |
| 20 | MCDADE HERBERT H Director | 2010-12-22 14:58:16 | 30,000 0 | 30,000 | Form 4 |
| 21 | Loh Evan Director | 2021-02-05 21:01:23 | 30,000 0 | 30,000 | Form 4 |
| 22 | Katzer Charles F SVP, Manufacturing Operations | 2010-02-09 17:15:17 | 20,000 9,381 | 29,381 | Form 5 |
| 23 | McAndrew Jamie VP, Controller, & CAO | 2023-09-05 19:21:25 | 26,433 1 | 26,434 | Form 3 |
| 24 | LOPEZ DAVID L Executive VP & General Counsel | 2011-08-01 08:33:46 | 17,456 8,033 | 25,489 | Form 4 |
| 25 | PEACOCK BRUCE Director | 2021-02-05 21:14:43 | 23,886 0 | 23,886 | Form 4 |
| 26 | ROSENTHALE MARVIN E Director | 2016-08-08 16:08:09 | 21,211 1,666 | 22,877 | Form 4 |
| 27 | Leone John R Director | 2021-02-05 21:05:38 | 22,473 0 | 22,473 | Form 4 |
| 28 | Joseph Mahady M Director | 2021-02-05 21:08:04 | 22,455 0 | 22,455 | Form 4 |
| 29 | Schreiber Brian D Director | 2021-02-05 21:09:28 | 17,069 0 | 17,069 | Form 4 |
| 30 | SEGAL ROBERT-MD Senior VP, Sci & Med Affairs | 2011-02-09 14:31:27 | 8,635 3,930 | 12,565 | Form 5 |
| 31 | DAVIS CYNTHIA VP, Business Admin & Treasury | 2005-06-14 17:00:05 | 10,000 0 | 10,000 | Form 4 |
| 32 | Fraser Craig President and CEO | 2024-10-09 07:46:52 | 8,638 1 | 8,639 | Form 4 |
| 33 | Strobeck Mark Director | 2023-08-25 18:03:00 | 5,750 0 | 5,750 | Form 4 |
| 34 | Geffken Daniel E. Director | 2023-08-29 16:37:19 | 5,225 0 | 5,225 | Form 4 |
| 35 | SCOTT ROBERT A Director | 2023-08-25 18:01:54 | 5,183 0 | 5,183 | Form 4 |
| 36 | Williams Leslie J. Director | 2023-08-25 18:03:42 | 5,183 0 | 5,183 | Form 4 |
| 37 | Simonson Steven SVP, Chief Medical Officer | 2024-07-24 17:28:26 | 2,687 0 | 2,687 | Form 4 |
| 38 | Templeton Mary B Esq SVP, Gen Counsel & Corp Sec | 2020-05-27 21:56:57 | 2,237 332 | 2,569 | Form 4 |
| 39 | CARMAN DIANE SVP & General Counsel | 2023-03-02 20:25:02 | 1,227 0 | 1,227 | Form 4 |
| 40 | KUCHARCHUK ANDREW ALBERT Director | 2025-08-05 16:43:08 | 0 0 | 0 | Form 3 |
| 41 | Kelly Leanne Director | 2025-01-14 16:17:38 | 0 0 | 0 | Form 3 |
| 42 | PELLETIER SAUNDRA L Director | 2024-08-14 16:24:25 | 0 0 | 0 | Form 3 |
| 43 | Latkin Jed Director | 2024-08-14 16:20:39 | 0 0 | 0 | Form 3 |
| 44 | McGowan Kathleen A Director, Finance & Controller Director | 2008-01-08 15:09:13 | 0 0 | 0 | Form 4 |
| 45 | LPH Investments Ltd 10% Owner | 2019-12-20 13:07:49 | 0 0 | 0 | Form 13D |
| 46 | Huang James Director | 2023-05-17 07:30:26 | 0 0 | 0 | Form 13D |
| 47 | Tattory John A Interim CFO | 2023-02-03 16:05:09 | 0 0 | 0 | Form 3 |
| 48 | China Cardiovascular Focus Ltd Lee's Pharmaceutical International Ltd 10% Owner | 2018-12-31 15:55:54 | 0 0 | 0 | Form 13D |
| 49 | Ivy Blue Holdings Ltd KPCB China Fund II L.P. KPCB China Associates II L.P. KPCB China Holdings II Ltd. 10% Owner | 2018-12-31 16:39:03 | 0 0 | 0 | Form 13D |
| 50 | Panacea Venture Healthcare Fund I L.P. 10% Owner | 2018-12-31 16:45:24 | 0 0 | 0 | Form 13D |
| 51 | LPH II Investments Ltd 10% Owner | 2019-12-20 13:05:01 | 0 0 | 0 | Form 13D |